SIC
HURA

SJS Investment Consulting’s TuHURA Biosciences HURA Stock Holding History

SJS Investment Consulting’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66 Buy
28
+10
+56% +$23 ﹤0.01% 2689
2026
Q1 		$33 Buy
+18
New +$22 ﹤0.01% 2311

Other funds holding HURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $481M AUM 20.5% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

SJS Investment Consulting's HURA Position: Q2 2026 in Review

SJS Investment Consulting increased its TuHURA Biosciences (HURA) stake by 56% in Q2 2026, buying an estimated $23 and bringing the position to 28 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #2689.

SJS Investment Consulting first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • SJS Investment Consulting held 28 shares of TuHURA Biosciences worth $66 as of Q2 2026.
  • SJS Investment Consulting bought 10 TuHURA Biosciences shares in Q2 2026, an estimated $23.
  • TuHURA Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2689 holding.
  • SJS Investment Consulting first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.